Abstract: Caspase activation has been shown to be a critical step in several models of neuronal apoptosis such as staurosporine treatment of human neuroblastoma SH-SY5Y cells and potassium deprivation of rat cerebellar granule neurons. One common event is the appearance of caspase-mediated 1 20-kDa nonerythroid ea-spectrin breakdown product (SBDP1 20). Second, inhibitors of the caspase family are effective blockers of such neuronal death. In this study, we report the appearance of caspase-mediated SBDP1 20 in excitotoxin-challenged fetal rat cerebrocortical neurons [N-methyl-o-aspartate (NMDA), a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid, and kainate] and rat cerebellar granule neurons (NMDA and kainate). A general caspase inhibitor, carbobenzoxy-Asp-CH 2OC (0) -2 ,6-dichlorobenzene (Z-D-DCB), blocked the formation of SBDP1 20 under these conditions and attenuated the observed NMDA-induced lactate dehydrogenase (LDH) release in both cell types. Furthermore, hydrolytic activity toward a caspase-3-preferred synthetic peptide substrate, acetyl-DEVD-7-amido-4-methylcoumarin, was significantly elevated in NM DA-treated granule neurons. Lastly, oxygen-glucose deprivation (OGD) -challenged cerebrocortical cultures also showed the appearance of SBDP12O. Again, Z-D-DCB blocked the SBDP12O formation as well as attenuated the LDH release from the OGD-challenged neurons. Taken together, the presence of caspase-specific SBDP1 20 and the neuroprotective effects of Z-D-DCB strongly suggest that caspase activation contributes at least in part to excitotoxin-and OGD-induced neuronal death.
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Apoptosis is a form of programmed cell death characterized by (a) cytoplasmic shrinkage, (b) nuclear DNA cleavages at the nucleosome linkage regions giving rise to the "DNA laddering" phenomenon when chromosomal DNA extract is electrophoresed on an agarose gel, and (c) chromatin condensation along the inside surface of the nuclear envelope (as a result of DNA fragmentation). Linnik et al. (1993) were the first group to report evidence for apoptosis in a rat global focal model by showing the presence of DNA laddering. Since then numerous reports have appeared documenting similar findings in either focal ischemia or kainate toxicity models (Heron et al., 1993; MacManus et al., 1993; Filipkowski et al., 1994; Li et a!., 1995; Chen et al., 1997) . On the other hand, several research groups found little or no evidence of classic apoptosis Scott and Hegyi, 1997; MacManus et al., 1997) . Terminal deoxyribonucleotidyl transferase-mediated biotin-I 6-dUTP nick endlabeling (TUNEL) is one method that has been misused for positive identification of apoptosis as it detects only the increase in content of fragmented DNA, which occurs in both apoptosis and necrosis (CharriautMarlangue and Ben-An, 1995) . Regarding excitotoxicity, Bonfoco et al. (1995) reported that high and low levels of excitotoxin challenge to neuronal cultures will result in necrosis and apoptosis, respectively (based on nuclear morphology). Yet, other research groups found little evidence for apoptosis when cerebrocortical cultures or cerebellar granule neurons were challenged with excitotoxins Heron et al., 1993; MacManus et al., 1997; Portera-Cailliau and Price, 1997) . It is clear that this area of research will benefit from a more definitive, preferably biochemical marker to define the presence of apoptosis.
In the last few years, an emerging theme in apoptosis is the activation of the caspase protease family (Nich-olson and Thornberry, 1997) . For example, caspase-3 (previously called CPP32, Yama, or apopain) is found to be almost universally activated in numerous cell types when subjected to various apoptotic challenges. Three biochemical events are observed during caspase-3 activation: (a) processing of intact 32-kDa caspase-3 to the 17-and 12-kDa dimeric form (Nicholson et al., 1995; Posmantur et al., 1997) , (b) fragmentation of the 11 3-kDa poly (ADP-nibose) polymerase (PARP) to an 89-kDa form (Lazebnik et al., 1994) , and (c) processing of nonerythroid cr-spectrin (a-spectrin; 280 kDa) into a 120-kDa spectrin breakdown product (SBDP12O) (Martin et al., 1995) . In fact, recently caspase-3, PARP, and a-spectrin processing have been reported in several neuronal apoptosis models, such as cultured neuroblastoma or neuronal cells exposed to staurosporine as well as cerebellar granule neurons subjected to potassium deprivation Nath et al., 1996a; Wiesner and Dawson, 1996; Armstrong et al., 1997; Ni et al., 1997) . In our previous study, we reported that although both calpain and caspase are capable of fragmenting a-spectrin, only caspase produces the distinctive SBDP12O (Nath et al., 1996a) . We also found that the SBDP12O was observed only in apoptotic neurons but not in necrotic neurons (Nath et al., 1996a) , which is consistent with the fact that caspase is only activated in apoptosis but not in necrosis (Armstrong et al., 1997) . Using SBDP 120 as a marker for apoptosis has the added advantage that commercial anti-a-spectrin antibodies react with rat, e.g., cerebellar granule neurons, and human, e.g., SH-SY5Y cells, a-spectrin (Martin et al., 1995; Nath et a!., 1996a) . Pharmacologically, several recently available caspase-specific inhibitors such as carbobenzoxy-Asp -CH 2OC (0)-2,6 -dichlorobenzene (Z-D-DCB), acetyl-YVAD-chloromethyl ketone, and carbobenzoxy-Val-Ala-Asp ( OMe) -fluoromethyl ketone I are found to be excellent neuronal apoptosis inhibitors (Loddick et al., 1996; Nath et al., 1996a,b; Schulz et al., 1996; Hara et al., 1997) . Also, they were ineffective against necrosis (Armstrong et al., 1997) . Therefore, these agents are also useful in defining the "apoptotic" component in a given form of neuronal injury.
In this study using both the fetal rat cerebrocortical cultures and rat cerebellar granule neurons, we examine the evidence for a caspase-mediated apoptotic component in excitotoxicity and hypoxic/hypoglycemic injury by monitoring the presence of SBDP12O and the effects of a cell-permeable caspase inhibitor, Z-D-DCB.
MATERIALS AND METHODS

Excitotoxicity in fetal rat cerebrocortical mixed cultures
All procedures described in this study were carried out in compliance with the NIH Guide for the Care and Use of Laboratory Animals, guidelines from the Society for Neuroscience, and the Parke-Davis Animal Use Committee. Cerebrocortical cells were harvested from fetal rats (SpragueDawley) on day 18 of gestation and cultured with DulbecCo's modified Eagle's mediumlFl2 medium containing 10% horse and 6% fetal bovine serum (heat-inactivated) in 96-well poly-L-lysine-coated plates as described previously (Hajimohammadreza et al., 1995) . Nonneuronal cell division was halted 3 days into culture by adding 35 p~g/ml uridine and 15~ig/ml 5-fiuoro-2'-deoxyuridine. On day 17 postplating, the cultures were washed three times with serum-free medium. Caspase inhibitor (Z-D-DCB) (Dolle et al., 1994 ) (made in-house at Parke-Davis) or calpain inhibitor I was added at this point for a 1-h preincubation, if for 15 mm (unless stated otherwise) before replacing with normal serum-free medium for 16 h, 200~uMa-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) or 200 p~Mkainate in serum-free medium for 16 h, or 1 nM maitotoxin or 0.5 ,uM staurosporine for 3 h before replacing with normal serum-free medium for 16 h. All cultures were maintained in a 37°Coxygenated incubator (21% 02, 8% C02, and 71% N2) except during medium changes. Various concentrations of NMDA have also been included. Under these conditions, we and others have reported that the neuronal population is selectively vulnerable to the applied excitotoxins. Neuronal death was assessed by measuring activity of the cytosolic enzyme lactate dehydrogenase (LDH) released into the medium as described previously (Koh and Choi, 1987; Hajimohammadreza et al., 1995) . Cellular proteins were extracted at 16 h as described previously (Wang et al., 1 996a) . We chose this time point for protein extraction to standardize better our comparison of proteolysis patterns with different neurotoxic challenges.
Excitotoxicity in cerebellar granule neurons
Cerebellar granule neurons were isolated from 7-day-old rat pups (Sprague-Dawley; Charles River Laboratories).
The meninges were removed from the cerebellum, and the minced tissue was trypsinized (0.25 mg/ml) for 15 mm at 37°C.The trypsinized tissue was then washed in 0.4 mg/mI DNase I for 5 mm at 1,000 rpm. The tissue was triturated three times in 0.4 mg/rn! DNase I. The combined supernatant was divided into four centrifuge tubes, and 3 ml of 4% (wt/vol) bovine serum albumin/i mM MgSO4 was layered underneath the supernatant. The cells were then centrifuged at 600 g and washed in HEPES-buffered salt solution (pH 7.3; 20 mM HEPES and 0.59 mM EDTA) for 5 mm at 600 g. The pellet was resuspended and cultured (about one cerebellum per 12-well plate) in 2 ml of feeding medium (Dulbecco's modified Eagle's medium plus 30 mM KC1, 10% fetal bovine serum, 5 mg/ml insulin, and 100 U/rn! penicillin/streptornycin) in a 37°Chumidified 5% CO2 incubator. Half of the medium was replaced with fresh medium containing 20~M cytosine arabinoside after 24 h. More than 95% population of cells in these cultures are neurons, based on routine inspection. At the beginning of an experiment, 7-day-old cultures were washed three times with serum-free Dulbecco's modified Eagle's medium without serum and pretreated with calpain inhibitor II (N-acetyl-Leu-Leu-Met-H; Calbiochem) or the caspase inhibitor Z-D-DCB for 2 h (ifdesired). The cultures were then washed with serum-free Dulbecco's modified Eagle's medium containing 30 mM KC1 and challenged with 200~M NMDA, AMPA (with 30 ,aM cyclothiazide), or kainate or 5 mM KCI (low K~) (Nath et al., 1996b) . Cultures were maintained for 16 h, at which time cell viability was monitored and protein extraction was performed. For cell viability here, owing to the lower plating density compared with the cerebrocortical cultures, we used the CytoTox 96 cytotoxicity kit (Promega) to measure LDH release into the medium.
Oxygen-glucose deprivation (OGD) in cerebrocortical cultures
Cerebrocortical cells were harvested from fetal rats (Sprague-Daw!ey) on day 18 of gestation and cultured with Dulbecco's modified Eagle's medium/F12 medium containing 10% horse and 6% fetal bovine serum (heat-inactivated) in 96-well poly-L-lysine-coated plates as described previously (Hajimohammadreza et al., 1995) . Nonneuronal cell division was halted 3 days into culture by adding 35
.tg/ml uridine and 15~.sg/ml5-fluoro-2 '-deoxyuridine. On day 17 postplating, the cultures were washed three times with serum-free medium.
was added at this point for a 1-h preincubation. The cultures were then challenged with hypoxia-hypoglycemia (90-300 mm with an exposure atmosphere in a gas incubator of 1% 02, 8% CO2. and 91% N2 in an exposure medium of Hanks' balanced salt solution containing 1.8 mM Ca 2~,0.8 mM Mg2~, and 0.2 g/L D-glucose) in the presence of the same inhibitor. The plates were then reconstituted to normal serum-free medium (with calpain inhibitor) and then placed in an oxygenated incubator (21% 02, 8% CO 2. and 71% N2) until 24 h after the experiment initiation. Normoxic/ normoglycemic cultures with the same number of medium changes were used as controls. Under these conditions, we found that only the neuronal population was selectively vulnerable to the challenge, whereas the more resistant astrocytes and microglial cells were spared. Neuronal death was then assessed by measuring the activity of the cytosolic enzyme LDH released into the medium ( 25-j.tl samples) as described earlier (Koh and Choi, 1987; Hajimohammadreza et al., 1995) . For protein extraction, the medium was aspirated, and the attached cells were washedtwice with 20 mM Tris-HC! (pH 7.4, room temperature), 155 mM NaC1, and 1 mM EDTA. Cells were lysed with sodium dodecyl sulfate lysis buffer, and cellular proteins were extracted as described before (Wang et al., i996a, b) .
Protein sample analysis
Protein concentration in tissue extract were estimated with a modified Lowry assay (Bio-Rad). Samples (15~tgof protein) were electrophoresed on sodium dodecy! sulfate-polyacrylamide gel electrophoresis (4-20% acrylamide) with a Tris-glycine running buffer system and then transferred onto a PVDF membrane with a Tris-glycine buffer system using a semidry electrotransferring unit (Bio-Rad) at 20 mA for 1.5-2 h. The blots were probed with an anti-a-spectrin (monoclonal; Chemicon) antibody. The blots were developed with nitro blue tetrazolium and 5-bromo-4-chloro-3-indolyl phosphate. Densitometnic analysis of western blots was performed using a color scanner (Umax UC630) and the NIH program Image 1.5.
Caspase-3-like activity in NMDA-treated granule neurons
To assay for caspase-3-like protease, 200~.uMNMDAtreated granule cells from three wells (20 h) were scraped off and centrifuged for 5 mm at 4°C.Cell pellets were lysed in a buffer containing 20 mM Tris-HC1 (pH 7.4 at 4°C), 150 mM NaC1, 1 mM dithiothreitol, 5 mM EDTA, 5 mM EGTA, and 1% (wt/vol) Triton X-lOO for 1 h. The cleared lysates were mixed with 50% (vol/vol) glycerol. Cell lysates were assayed with 100~M acetyl-DEVD-7-amido-4-methylcoumarin (Ac-DEVD-MCA; Bachem Bioscience), 100mM HEPES, 10% glycerol, 1 mM EDTA, 10 mM dithiothreitol, and 10 ,iM Z-D-DCB (optional). Fluorescence (excitation, 380 ± 15 nm; emission, 460 ± 15 nm) was measured at 60 mm with a Cytofluor 2300 apparatus.
RESULTS
Evidence for caspase-mediated SBDP12O in excitotoxin-challenged cerebrocortical cultures
We have previously established that exposure of mixed cerebrocortical cultures to high levels of excitotoxins results in neuronal death (Hajimohammadreza et a!., 1995) . The mode of cell death is presumably necrotic, but recently such a notion is being challenged, as evidence for apoptosis has been reported in several in vivo neurodegeneration models that involves excitotoxicity and hypoxia (MacManus et al., 1997; Cailliau and Price, 1997). Our previous work (Nath et a!., 1996b) has established that (a) although both caspase and calpain can give rise to an SBDP of~150 kDa (SBDP15O), calpain can produce an additional SBDP of 145 kDa (SBDP145), whereas caspase selectively produces SBDP of 120 kDa (SBDPJ2O), and (b) calpain-mediated SBDPs occur in both neuronal apoptosis and necrosis paradigms, whereas caspasemediated spectrin breakdown only occurs in apoptosis. Therefore, we examined the spectrin breakdown pattern after cerebrocortical cultures were exposed to toxic levels of three excitotoxins (NMDA, AMPA, and kainate). In the control cultur,es, a-spectnin was found to be mostly in the intact 280-kDa form, with some minor background signal of its fragments (Fig. 1A) .
On 200
1aM NMDA challenge (15 mm in the absence of Mg 2+ followed by a 16-h recovery in normal medium), the intact spectnin signal was reduced, whereas SBDP15O and SBDP145 were observed, along with the appearance of an SBDP12O. We noted that the same spectnin breakdown pattern (including the presence of SBDP12O) was observed when the cultures were challenged with 500 1uM NMDA in the presence of 0.8 mMMg
2~(data not shown). In the case of 200
1uM AMPA (for 16 h), the level of SBDP12O was weaker but significant, and with 200 1uM kainate (for 20 h), all three SBDPs were again observed. We quantified the level of SBDP12O on excitotoxin challenges. In all three cases, the increase was significant (Fig.  1C) . Whereas an SBDP of 150 kDa has been reported previously under similar conditions Manev et a!., 1991; Wang et al., 1996a,b) , this is the first report of the presence of lower-molecular-weight SBDP suggestive of caspase attack. We also performed a time course experiment of NMDA challenge (200~tM) and showed that the SBDP 120 appeared as early as 6 h after initiation of NMDA challenge (data not shown).
To confirm that the SBDP12O observed here was derived from caspase activation, we took advantage of our previous finding that a selective caspase inhibitor, Z-D-DCB, is cell-permeable and particularly effective in blocking the SBDP12O in two cell-based neurona! apoptosis models (Nath et a!., 1996a) . Cultures were preincubated with Z-D-DCB (for 1 h) before excitotoxin challenges. As predicted, the presence of Z-D-DCB completely abolished the formation of SBDPI 20 associated with all three excitotoxin treatments ( Fig.  lB and C) . As reported before, SBDPI45 and SBDP15O were not inhibited by Z-D-DCB because calpain also contributes to these fragmentations.
Caspase inhibitor attenuated excitotoxicity in cerebrocortica! cultures As caspase activation was observed in excitotoxinchallenged neurons, we examined if caspase activity contributes to neuronal death under these excitotoxic conditions. NMDA challenge was done either in the absence ( Fig. 2A) or in the presence of 0.8 mMMg 2 (  Fig. 2B) . Because Mg2~is a voltage-dependent blocker of the NMDA receptor, in the presence of Mg2~,higher concentrations of NMDA were needed to provide the same levels of toxicity as in its absence (compare Fig. 2B with 2A) . In both cases, we found that the presence of Z-D-DCB (30 ,aM) significantly attenuated neurona! death at 100~uM NMDA (Mg2~-free) and 200~aM NMDA (with Mg2~),respectively ( Fig. 2A and B) . In parallel, we found that kainate toxicity (at 100, 200, and 500~M) was both partially and significantly attenuated by 30 ,uM Z-D-DCB. Although there appears to be a trend of attenuation toward AMPA toxicity, no statistical significance was achieved. We suspected that higher concentrations of Z-D-DCB (50-100
1.tM) might provide further protection against these excitotoxin challenges. We also performed glutamate receptor binding assays~N-1-(2-thieny!) cyclohexyl 1-3,4-[piperidyl -3,4- (Hajimohammadreza et al., 1995) . We found that 30 1aM Z-D-DCB did not significantly inhibit glutamate agonist binding (data not shown). Thus, the attenuation of excitotoxicity was unlikely to be an effect of direct glutamate receptor antagonism.
3H (N)] piperidine ({3H]TCP), [3H]AMPA, and [3H]kainate] in the presence of various concentrations of Z-D-DCB
Caspase activation in cerebellar granule neurons challenged with NMDA and kainate
To examine if caspase activation also occurs during excitotoxicity in other neuronal cell types, we used another culture model: cerebellar granule neurons. It has been shown previously that glutamate treatment induces a-spectnin breakdown and cell injury in this cell type (Siman and Noszek, 1988) . This model has the added advantage that spontaneous apoptosis can be invoked by simply lowering the extracellular potassium from 30 to 5 mM (Nath et al., 1996a) , which can be used as a positive apoptosis control. Again, we first examined the a-spectnin breakdown patterns in excitotoxin-challenged granule neurons (Fig. 3) . Only the results for NMDA and kainate are reported here because AMPA challenge did not significantly induce toxicity or a-spectrin breakdown in this model. The lack of AMPA toxicity in granule neurons 7 days in vitro is consistent with a previous report showing that half-maximal AMPA toxicity is not achieved until 13-16 days in vitro, a property that is correlated with GluRl receptor expression (Hack et al., 1995) . In the present study, in control cells (maintained in 30 mM potassium), we noted that besides the intact a-spectnin, there are detectable levels of SBDPs, most likely a result of background apoptosis (Fig. 3) . Both NMDA (200~M for 20 h) and kainate (200 ,iM for 20 h) resulted in SBDP15O and SBDP145. SBDP12O was also present with NMDA challenge and to a lesser extent with kainate challenge (Fig. 3) . It is important to point out that the levels of SBDPI2O in NMDA/ kainate challenges were much lower than that in low potassium-treated cultures (Fig. 3) . As in their cerebrocortical culture counterpart, the caspase inhibitor Z-D-DCB (50 /2M) fully blocked SBDP12O in NMDAand kainate-challenged cells. In contrast, calpain inhibitor II only attenuated the ca!pain-mediated SBDP 145 while having no effect on SBDP 120.
Another advantage of this model is that this culture system contains >95% neurons, with little glial contamination. We reasoned that we could attempt to detect caspase-3-like activity using a fluorogenic sub- strate. Previously, we developed a simple method to assay for caspase-3-!ike activity in Triton X-100 cell extracts. Using low potassium as the apoptotic challenge, we found that Ac-DEVD-AMC hydrolytic activity was drastically elevated, presumably owing to the reported processing and the associated activation of caspase-3 (Nath et al., 1996b) . In the present study, we prepared cell extracts from control or NMDA-treated cerebellar granule neurons. We found that NMDA treatment significantly increased the caspase-3-like activity, although it is much lower than that observed in low potassium-treated cells, by comparison (Fig. 4A) . As expected, Z-D-DCB (30 ,uM) but not calpain inhibitor II (10~tM) significantly blocked the NMDAinduced increase of Ac-DEVD-AMC-hydrolytic activity (Fig. 4A) . As a measurement of cell death, NMDAinduced LDH release from cerebellar granule cells was also monitored (Fig. 4B) . We found that the NMDAmediated increase in LDH release was again partially but significantly reduced by 50
1.tM Z-D-DCB (Fig.  4B ). These data suggest that caspase activation also contributes to NMDA-mediated excitotoxicity in cerebellar granule neurons.
Evidence for caspase activation during hypoxiahypoglycemia in cerebrocortical cultures
Previous studies have strongly implicated glutamate toxicity as mediating hypoxia-hypoglycemia-induced neuronal injury both in vitro and in vivo (Goldberg et a!., 1987; Kaku et al., 1993) . Similarly, we (Hajimo- hammadreza et al., 1995; Wang et a!., 1996a,b) have reported a-spectnin fragmentation occurred in cerebrocortical cultures subjected to hypoxic-hypoglycemic challenges. As we have reported previously, under our experimental conditions, 165-225 mm of OGD induced irreversible cell injury and death, despite subsequent recovery in normal oxygen and glucose levels (up to 24 h) (Hajimohammadreza et al., 1995) . Under these conditions, we now carefully reexamine the pattern of a-spectnin breakdown. In control cells under normoxic and normoglycemic conditions, spectrin was essentially in its intact form (Fig. 5A and B) . On increasing duration of OGD (165-195 mm) the levels of SBDP15O and SBDP145 dramatically increased (measured at 20 h after initiation of OGD challenge and recovery). Concomitantly, lower but significant levels of SBDPI2O were clearly detected with 165-195 mm of OGD challenge (Fig. 5A and B) . Again, whereas calpain inhibitor 11(10 jiM) attenuated the level of calpain-mediated SBDP 145 in OGD-treated cells, Z-D-DCB drastically reduced the OGD-induced SBDP12O signals at all three time points examined (Fig. 5A and B) . It is interesting that when the level of calpain-mediated SBDP 145 versus caspase-mediated SBDP12O was plotted against OGD time, it appears that calpain activation parallels caspase activation (Fig. 5C ).
Next, we examined the potential neuroprotective effects of Z-D-DCB against OGD-induced cell death. As we have shown previously (Hajimohammadreza et a!., 1995) , increasing duration of OGD progressively increased LDH release from these cultures measured 20 h after deprivation initiation (Fig. 6) . Under these conditions, we found that Z-D-DCB dose-dependently (30 and 100 jiM) and significantly attenuated the OGD-induced LDH release. Consistent with this, another caspase inhibitor, Z-VAD(OEt)-DCB (30 jiM), again provided a similar level of protection (Fig. 6A) . When compared with an NMDA receptor antagonist, CPP (100 jiM), we found that the caspase inhibitors provided lower levels of neuroprotection. We also note that slightly higher concentrations of Z-D-DCB were needed to reduce LDH release than those needed to inhibit SBDPI2O (Fig. 6B) . We suspected that to achieve significant cytoprotection, one needs higher concentrations of Z-D-DCB to preserve most of its cellular proteins. Furthermore, there are likely other non-caspase pathways for cell death also occurring in parallel.
DISCUSSION
In this report, we show, for the first time, direct evidence for caspase activation during excitotoxicity and OGD in cultured neurons by using two criteria: (a) increase in content of the caspase inhibitor-sensitive SBDP12O (Figs. 1, 3 , and 5) and (b) attenuation of the associated neuronal death by a caspase inhibitor (Figs. 2, 4B , and 6). We also illustrated that the role of caspase in excitotoxicity is model-independent as we have essentially the same findings using either rat cerebrocortical mixed cultures (Figs. 1 and 2 ) or rat cerebellar granule neurons (Figs. 3 and 4) . In the latter model, because the large majority of cells were neurons, we were also able to detect an increase of caspase-3-like activity in cells on NMDA challenge (Fig.  4A) . Recently, others have reported evidence of apoptosis in cultured neurons challenged with excitotoxins (Bonfoco et al., 1995) and hypoxia-hypoglycemia (Gwag et a!., 1995; Gottron et al., 1997) , based on morphological criteria or the presence of DNA laddering. Because we used a biochemical marker that earmarks an apoptosis-linked event (caspase activation), our evidence is more compelling and unequivocal. In the previous study by Bonfoco et a!. (1995) , apoptosis was more evident with lower concentrations of NMDA. In our study, the SBDP12O is found at low (50 and 100 jiM) as well as high (200-500 jiM) NMDA concentrations but is more prominent at higher NMDA concentrations, which might simply reflect the higher levels of injury (Figs. 1 and 3 and data not shown). However, in terms of LDH release, consistent with Bonfoco et a!. (1995) , we found significant protection at 100 jiM NMDA but not at 200, 300, or 500 jiM (Mg 2~-free; Fig. 2 ). The previous study did not address kainate toxicity; however, we found that the protections provided by Z-D-DCB were significant at higher concentrations of kainate. Lastly, with OGD, it was obvious that Z-D-DCB protection is inversely related to the duration of deprivation. It is important to note again that in all excitotoxicity models we examined, the level of caspase activation was much lower than that observed when a strict apoptosis inducer was used (staurosporine in cortical cultures and potassium deprivation in granule neurons) (Figs. 1A and 3) . Likewise, Z-D-DCB only provided a partial protection against excitotoxic and hypoxic-hypoglycemic cha!-lenges (Figs. 2, 4B , and 6).
A simplistic interpretation of these data is that apoptosis is only a partial component in these forms of neuronal injury. Maybe under these neurotoxic conditions, the injured neurons are subjected to a mixture of cell death signals (MacManus et al., 1997; PorteraCailliau and Price, 1997) . It is possible that while necrotic events are occurring, the apoptosis machinery is also being activated, e.g., caspase activation. Following this hypothesis, one would expect to find evidence for both necrosis and apoptosis, depending on the degree and the duration of the challenge and other factors. Also, if both necrosis and apoptosis are occurring, their distinctive features may not be as easily recognized. For example, chromosomal DNA may be fragmented by an apoptosis-linked endonuclease ( s) at the nuc!eosome linker regions, producing discrete DNA laddering patterns. However, these fragments could be further degraded by the less discriminative necrosis-linked endonuclease activities under a mixed apoptosis-necrosis condition. This could potentially explain the lack of evidence for apoptosis during glutamate toxicity recently reported by several groups Heron et a!., 1993; MacManus et a!., 1997; Portera-Cailliau and Price, 1997) .
The use of SBDPs as markers of neurodegeneration is not a novel idea. An increase of the SBDP15O content has been reported in vivo in models for excitotoxicity (Vartanian et a!., 1996) , focal ischemia , and global ischemia (Roberts-Lewis et al., 1994) and in cell cultures subjected to excitotoxins ( Siman and Noszek, 1988) and OGD (Wang et a!., 1996a,b) . However, those reports preceded the recent discovery that a-spectrin is a substrate for caspases (Nath et a!., 1996a; Cryns et a!., 1996; Vanags et al., 1996) . Thus, it was presumed that neurodegenerationlinked a-spectrin fragmentation was only mediated by calpain. Our recent study clearly demonstrates that calpain can produce both SBDP15O and SBDP145, whereas caspase also produces a distinct SBDP15O and SBDP 120. We have recently confirmed these findings by identifying all four cleavage sites (K. K. W. Wang et al., manuscript submitted). SBDPI2O is easily distinguished from other fragments because of its lower molecular weight and its high sensitivity to the caspase inhibitor Z-D-DCB (Nath et a!., l996a) (Figs. 1, 3 , and 5). In principle, PARP cleavage is an equally wellestablished marker for caspase-3 activation and apoptosis (Lazebnik et al., 1994) . However, the shortcoming is that the commercially available mouse monoclonal antibody only detects the human PARP (clone C-2-10; SA250; BioMol), whereas a rabbit polyclonal antibody against bovine PARP antibody (SA252; BioMol) cross-reacts with PARP in rats or mice only weakly. In fact, it is extremely difficult to demonstrate quantitatively the small increases in level of the 89-kDa PARP breakdown product using this antibody, e.g., in excitotoxicity (data not shown). On the other hand, as we noted earlier, the two commercially available anti-a-spectrin antibodies (MAB 1622 from Chemicon and FG6090 from Affiniti; raised against chicken a-spectrin) cross-react with a-spectrin from the brain in many species (human, rat, and mouse) (Nath eta!., 1996a) . Beside the intact a-spectrin, these anti-spectrin antibodies readily detect the SBDP12O. Thus, we would like to propose that the SBDP12O is an excellent marker for neuronal apoptosis.
Based on the appearance of the caspase-specific SBDPI 20 and the neuroprotective effects of a caspase inhibitor, Z-D-DCB, in excitotoxin challenges in two neuronal cell types (cerebrocortical neurons and cerebellar granule neurons), we conclude that caspase activation is triggered under excitotoxic conditions. Similarly, OGD also triggers caspase activation in cerebrocortical cultures. Therefore, it is tempting to suggest the potential therapeutic values of caspase inhibitors in neurodegenerative conditions where glutamate toxicity is implicated. In support of that, Hara et al. (1997) recently reported that a caspase inhibitor, carbobenzoxy-Val-Ala-Asp( OMe) -fluoromethyl ketone, was neuroprotective in a rat mode! of focal ischemic and excitotoxic brain damage.
